13F filing recap · Q3 2018
What did ARK Invest buy in Q3 2018?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every ARK-managed account, including accounts that belong to no fund below.
Stock value
$3.31B
Positions
202
Estimated turnover
35.0%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
AMDAdvanced Micro Devices Inc$19.77Mreported value+640.2K sharesOPRAOpera Ltd$5.68Mreported value+631.9K sharesRUBYUSDRubius Therapeutics, Inc.$4.52Mreported value+188.3K sharesGRUBGrubhub Inc.$3.58Mreported value+25.8K sharesYYJoyy Inc$3.51Mreported value+46.9K sharesONCBeone Medicines Ltd.$3.48Mreported value+20.2K sharesNXPINxp Semiconductors N.v.$2.91Mreported value+34.0K sharesKTOSKratos Defense & Security Solutions, Inc.$1.09Mreported value+74.1K sharesATTUAttunity Ltd.$842.0Kreported value+44.6K sharesSPNSSapiens International Corporation N.v.$703.0Kreported value+53.2K sharesMDTMedtronic Plc$648.0Kreported value+6.6K sharesNTECIntec Pharma Ltd$609.0Kreported value+107.8K sharesTGTRTogether Pharma Ltd$513.0Kreported value+285.2K sharesGLMDGalmed Pharmaceuticals Ltd.$487.0Kreported value+35.8K sharesEBIXQEbix, Inc.$147.0Kreported value+1.9K sharesEVKIFEvonik Industries AG$59.0Kreported value+1.6K sharesHELKFHenkel AG & Co. Kgaa$53.0Kreported value+499 shares9449Gmo Internet Group, Inc.$14.0Kreported value+800 sharesONCESpark Therapeutics Inc$7.0Kreported value+129 shares